Cargando…

Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate

Detalles Bibliográficos
Autores principales: Singh, UP, Srivastava, JK, Bhat, HR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474649/
http://dx.doi.org/10.1186/2047-2994-4-S1-I2
_version_ 1782377310363582464
author Singh, UP
Srivastava, JK
Bhat, HR
author_facet Singh, UP
Srivastava, JK
Bhat, HR
author_sort Singh, UP
collection PubMed
description
format Online
Article
Text
id pubmed-4474649
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44746492015-06-25 Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate Singh, UP Srivastava, JK Bhat, HR Antimicrob Resist Infect Control Innovation Academy Presentation BioMed Central 2015-06-16 /pmc/articles/PMC4474649/ http://dx.doi.org/10.1186/2047-2994-4-S1-I2 Text en Copyright © 2015 Singh et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Innovation Academy Presentation
Singh, UP
Srivastava, JK
Bhat, HR
Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate
title Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate
title_full Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate
title_fullStr Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate
title_full_unstemmed Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate
title_short Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate
title_sort structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate
topic Innovation Academy Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474649/
http://dx.doi.org/10.1186/2047-2994-4-S1-I2
work_keys_str_mv AT singhup structurebasedoptimizationanddiscoveryofnovel135triazinederivativesasbacterialtranslationinhibitorwithfavourablemetabolicfate
AT srivastavajk structurebasedoptimizationanddiscoveryofnovel135triazinederivativesasbacterialtranslationinhibitorwithfavourablemetabolicfate
AT bhathr structurebasedoptimizationanddiscoveryofnovel135triazinederivativesasbacterialtranslationinhibitorwithfavourablemetabolicfate